S66 - Fentanyl Utilization During Extracorporeal Membrane Oxygenation and Risk of Methadone Treatment Among Pediatric ECMO Survivors

Presenting Author(s)

• 

  Ruby Barq, MD (she/her/hers)

  Postdoctoral Research Fellow, General Surgery Resident
  Children's Hospital Los Angeles, Virginia Commonwealth University Health
  Los Angeles, California, United States

Co-Author(s)

• SO

  Shadassa Ourshalimian, MPH

  Biostatistician
  Children's Hospital Los Angeles
  Los Angeles, California, United States
• OK

  Olivia A. Keane, MD, MS

  General Surgery Resident Physician
  Emory University School of Medicine
  Atlanta, Georgia, United States
• LN

  Lara Nelson, MD

  Children's Hospital Los Angeles
  Los Angeles, California, United States
• AL

  Ashwini Lakshmanan, MD, MS, MPH, FAAP

  KPSOM
  Pasadena, California, United States
• HL

  Henry Lee, MD

  Department of Pediatrics, UCSD School of Medicine
  San Diego, California, United States
• EK

  Eugene S. Kim, MD

  Professor of Surgery and Pediatrics
  Division of Pediatric Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
  Los Angeles, California, United States
• SH

  Susan R. Hintz, MD, MS

  Robert L Hess Professor of Neonatal and Developmental Medicine
  Stanford University School of Medicine
  Palo Alto, California, United States
• AK

  Asavari Kamerkar, DO

  Medical Director, ECMO Department
  CHLA
  Los Angeles, California, United States
• LK

  Lorraine I. Kelley-Quon, MD MSHS

  Assistant Professor, Division of Pediatric Surgery and Population and Public Health Sciences
  Children's Hospital Los Angeles
  Los Angeles, California, United States